Abstract:Poly(L-glutamic acid) (PLG) and its derivatives, which are biodegradable and biocompatible, are one kind of the most widely investigated synthetic polypeptides as biomedical materials benefited from their pH-responsive property (pK(a) similar to 4.1) and modifiable side carboxyl group. In this work, PLG was synthesized via a two-step procedure. Poly(gamma-benzyl-L-glutamate) (PBLG) was first synthesized by the ring-opening polymerization of gamma-benzyl-L-glutamate-N-carboxyanhydride (BLG-NCA) using n-hexylamine as initiator, and then PLG was prepared by the deprotection of benzyl groups in PBLG. PLG microsphere was prepared by the oil-in-oil (O/O) anhydrous emulsion method utilizing N, N-dimetylformamide as an inner oil phase and corn oil as an outer oil phase. Rifampicin, a model drug, was loaded into the PLG microsphere, and the drug loading capacity and entrapment efficiency were revealed. The scanning electron microscopy micrograph indicated that the drug-loaded microsphere exhibited spherical morphology with narrow size distribution and average diameter at about 9.0 mu m. To investigate the application of PLG microsphere in oral drug delivery (especially for enteric-coated drugs), the in vitro rifampicin release experiments in simulated gastric or intestinal fluid were performed. In vitro release results revealed that the release of rifampicin from microsphere was highly dependent on pH. In detail, less amount of rifampicin was released in simulated gastric fluid, while the quicker release of rifampicin occurred in simulated intestinal fluid. It was because that the deprotonation of carboxyl groups in PLG caused the loose, expansion, and even disintegration of PLG microsphere in simulated intestinal fluid. Moreover, the morphology of microsphere in simulated gastric fluid was different from that in simulated intestinal fluid, which further confirmed the pH-sensitive property of microsphere. Additionally, in vitro methyl thiazolyl tetrazolium assays demonstrated that the PLG microsphere was biocompatible. Therefore, the biocompatible PLG microsphere with the intelligent pH-triggered drug release should be promising for application in oral drug delivery.

ERYTHROMYCIN POLYLACTIC ACID MICROSPHERES FOR LUNG TARGETING

PREPARATION AND PROPERTIES OF MOLECULARLY IMPRINTED POLYMER MICROSPHERES FOR ERYTHROMYCIN

Preparation,in vitro and in vivo evaluation of actively lung targetable microspheres for paclitaxel delivery

The preparation of streptomycin sulfate gelatin microspheres for lung targeting

Preparation of Erythromycin-Imprinted Polymeric Microspheres by Emulsion Polymerization and Their Adsorption Properties

Preparation of Microsphere Containing Azithromycin with Polylactic Acid and Its Release Property in Vitro

Preparation and Testing of Cefquinome-Loaded Poly Lactic-Co-glycolic Acid Microspheres for Lung Targeting.

Monosized Polymeric Microspheres Designed for Passive Lung Targeting: Biodistribution and Pharmacokinetics after Intravenous Administration

Preparation of Lung Targeting Azithromycin Liposomes and Its Tissue Distribution in Mice

Direct synthesis of poly(D,L-lactic acid) by melt polycondensation and its application in drug delivery

Preparation for Lung Targeting Microspheres of Enrofloxacin

Inhalable Functional Mixed-Polymer Microspheres to Enhance Doxorubicin Release Behavior for Lung Cancer Treatment

Preparation and in Vitro Evaluation of Etoposide-Loaded PLGA Microspheres for Pulmonary Drug Delivery.

Lung-Targeting Lysostaphin Microspheres for Methicillin-Resistant Staphylococcus Aureus Pneumonia Treatment and Prevention.

Plga Microspheres as a Delivery Vehicle for Sustained Release of Tetracycline: Biodistribution in Mice After Subcutaneous Administration

Poly(L-glutamic Acid) Microsphere: Preparation and Application in Oral Drug Controlled Release

Preparation and properties of vancomycin-loaded PLA-PEG-PLA microspheres by electrostatic spray technology

Preparation and in vitro release studies of thymosin-loaded PLA microspheres

Triple anti-tuberculosis drug polylactic acid-glycolic acid microsphere and its slow-release in vivo, an experimental study

Fabrication and in vitro drug release study of microsphere drug delivery systems based on amphiphilic poly-alpha,beta-[N-(2-hydroxyethyl)-L-aspartamide]-g-poly(L-lactide) graft copolymers.

Engineering large porous microparticles with tailored porosity and sustained drug release behavior for inhalation